SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-21-016232
Filing Date
2021-07-06
Accepted
2021-07-06 16:15:30
Documents
2
Group Members
MATTHEWS LANE CAPITAL PARTNERS LLCMLCP GLL FUNDING LLC

Document Format Files

Seq Description Document Type Size
1 form13d.htm SC 13D 129172
2 ex1.htm EX-1 10941
  Complete submission text file 0001493152-21-016232.txt   141552
Mailing Address 1199 PARK AVENUE #17A NEW YORK NY 10128
Business Address
Silvers Daniel B. (Filed by) CIK: 0001468195 (see all company filings)

Type: SC 13D

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Subject) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90218 | Film No.: 211074253
SIC: 2834 Pharmaceutical Preparations